Skip to Content

Learn more about the main diseases in each of Almirall's key therapeutic areas: respiratory, dermatology, gastroenterology and pain.


Research and development lie at the very heart of our organisation. Discover what's coming next, as we experience the most dynamic pipeline in our history.

Committed to the medicines of the future

"To those of you who have trusted us in the past, make a place for us in the future." Watch the video to hear about our determination and innovation, to achieve the dreams of those who came before us. At Almirall, the best is yet to come!

Career Opportunities

A career at Almirall means developing your talent and boosting your professional growth. Find out more about our opportunities and what a future at Almirall could look like for you.


Almirall's aclidinium bromide/formoterol fumarate recommended for approval in Europe to treat COPD

Positive CHMP opinion is an important step in making this new respiratory therapy available to treat Chronic Obstructiv ...


Almirall agrees strategic transaction with astrazeneca in respiratory disease

Agreement allows Almirall to evolve its respiratory strategy to maximise the return and value of ...


Medical information and resources exclusively for healthcare professionals.

Footer Options